Smithfield Trust’s Regeneron Pharmaceuticals REGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$65K Sell
123
-14
-10% -$7.4K ﹤0.01% 523
2025
Q1
$89K Hold
137
﹤0.01% 451
2024
Q4
$98K Hold
137
﹤0.01% 451
2024
Q3
$142K Sell
137
-4
-3% -$4.15K 0.01% 399
2024
Q2
$146K Sell
141
-8
-5% -$8.28K 0.01% 375
2024
Q1
$144K Buy
149
+8
+6% +$7.73K 0.01% 381
2023
Q4
$125K Hold
141
0.01% 389
2023
Q3
$117K Buy
141
+14
+11% +$11.6K 0.01% 385
2023
Q2
$93K Hold
127
0.01% 444
2023
Q1
$106K Hold
127
0.01% 411
2022
Q4
$93K Hold
127
0.01% 414
2022
Q3
$90K Hold
127
0.01% 406
2022
Q2
$78K Hold
127
0.01% 461
2022
Q1
$90K Buy
127
+23
+22% +$16.3K 0.01% 456
2021
Q4
$67K Hold
104
﹤0.01% 519
2021
Q3
$64K Hold
104
﹤0.01% 526
2021
Q2
$58K Hold
104
﹤0.01% 527
2021
Q1
$50K Hold
104
﹤0.01% 558
2020
Q4
$51K Sell
104
-161
-61% -$79K ﹤0.01% 524
2020
Q3
$148K Sell
265
-1
-0.4% -$558 0.01% 333
2020
Q2
$166K Buy
+266
New +$166K 0.01% 303
2019
Q2
Sell
-66
Closed -$27K 981
2019
Q1
$27K Buy
+66
New +$27K ﹤0.01% 565
2018
Q1
Sell
-76
Closed -$29K 1090
2017
Q4
$29K Buy
76
+7
+10% +$2.67K ﹤0.01% 612
2017
Q3
$31K Buy
69
+15
+28% +$6.74K ﹤0.01% 592
2017
Q2
$27K Hold
54
﹤0.01% 616
2017
Q1
$21K Buy
+54
New +$21K ﹤0.01% 636
2014
Q1
Sell
-24
Closed -$7K 857
2013
Q4
$7K Buy
+24
New +$7K ﹤0.01% 733